SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012081
Filing Date
2024-08-13
Accepted
2024-08-13 17:22:00
Documents
85
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240630x10q.htm   iXBRL 10-Q 2626431
2 EX-10.11 tmb-20240630xex10d11.htm EX-10.11 46618
3 EX-31.1 tmb-20240630xex31d1.htm EX-31.1 15487
4 EX-31.2 tmb-20240630xex31d2.htm EX-31.2 14991
5 EX-32.1 tmb-20240630xex32d1.htm EX-32.1 9777
6 EX-32.2 tmb-20240630xex32d2.htm EX-32.2 9206
  Complete submission text file 0001558370-24-012081.txt   10241391

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20240630.xsd EX-101.SCH 67972
8 EX-101.CAL tmb-20240630_cal.xml EX-101.CAL 54945
9 EX-101.DEF tmb-20240630_def.xml EX-101.DEF 281221
10 EX-101.LAB tmb-20240630_lab.xml EX-101.LAB 575747
11 EX-101.PRE tmb-20240630_pre.xml EX-101.PRE 471716
88 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240630x10q_htm.xml XML 1746605
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42143 | Film No.: 241203042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)